Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Journey Medical (DERM) Net Margin: 2020-2024

Historic Net Margin for Journey Medical (DERM) over the last 5 years, with Dec 2024 value amounting to -26.14%.

  • Journey Medical's Net Margin rose 321.00% to -13.13% in Q3 2025 from the same period last year, while for Sep 2025 it was -14.38%, marking a year-over-year increase of 1736.00%. This contributed to the annual value of -26.14% for FY2024, which is 2127.00% down from last year.
  • Per Journey Medical's latest filing, its Net Margin stood at -26.14% for FY2024, which was down 437.14% from -4.87% recorded in FY2023.
  • Over the past 5 years, Journey Medical's Net Margin peaked at 11.11% during FY2020, and registered a low of -69.68% during FY2021.
  • Over the past 3 years, Journey Medical's median Net Margin value was -26.14% (recorded in 2024), while the average stood at -23.74%.
  • In the last 5 years, Journey Medical's Net Margin plummeted by 8,079bps in 2021 and then spiked by 3,535bps in 2023.
  • Yearly analysis of 5 years shows Journey Medical's Net Margin stood at 11.11% in 2020, then crashed by 8,079bps to -69.68% in 2021, then soared by 2,947bps to -40.22% in 2022, then spiked by 3,535bps to -4.87% in 2023, then slumped by 2,127bps to -26.14% in 2024.